GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (XTER:5CV) » Definitions » Unpaid Loss & Loss Reserve

CureVac NV (XTER:5CV) Unpaid Loss & Loss Reserve


View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Unpaid Loss & Loss Reserve?

Unpaid Loss & Loss Reserve only applies to insurance companies.


CureVac NV Business Description

Industry
Traded in Other Exchanges
Address
Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.